Recombinant anti-HIV MAP30, a ribosome inactivating protein: against plant virus and bacteriophage

The ribosome inactivating proteins (RIPs) efficiently decrease the microbial infections in plants. Momordicacharantia MAP30 is a type I RIP that has not been investigated against plant viruses or bacteriophages. To evaluate of these activities, the recombinant MAP30 (rMAP30) was produced in the hairy roots of Nicotianatabacum. Inoculation of 3 mu g of transgenic total protein or 0.6 mu g of rMAP30 against 0.1 mu g of TMV reduced the leaf necrotic spots to 78.23% and 82.72%, respectively. The treatment of 0.1 mu g of CMV with rMAP30 (0.6 mu g) showed the reduction in the leaf necrotic spots to 85.8%. While the infection was increased after rMAP30 dilution. In the time interval assays, the leaves were first inoculated with 1 mu g of rMAP30 or 0.1 mu g of purified TMV or CMV agent for 6 h, then virus or protein was applied in order. This led the spot reduction to 35.22% and 67% for TMV, and 38.61% and 55.31% for CMV, respectively. In both the pre- and co-treatments of 1:10 or 1:20 diluted bacteriophage with 15 mu g of transgenic total protein, the number and diameter of the plaques were reduced. The results showed that the highest inhibitory effect was observed in the pre-treatment assay of bacteriophage with transgenic total protein for 24 h. The decrease in the growth of bacteriophage caused more growth pattern of Escherichiacoli. The results confirm that rMAP30 shows antibacterial activity against Streptococcusaureus and E.coli, antifungal activity against Candidaalbicans, and antiviral activity against CMV and TMV. Moreover, rMAP30 exhibits anti-phage activity for the first time. According to our findings, rMAP30 might be a valuable preservative agent in foods and beverages in the food industry as well as an antiviral and antimicrobial mixture in agriculture.